Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 69.37% is 78% above its 5-year average of 38.99%, near the high end of its 5-year range (13.51%–69.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.51% above its 12-month average of 59.54%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 69.37%.
DEBT TO ASSETS RATIO
69.37%
DEBT TO ASSETS RATIO AVG TTM
59.54%
DEBT TO ASSETS RATIO AVG 3Y
50.62%
DEBT TO ASSETS RATIO AVG 5Y
38.99%
DEBT TO ASSETS RATIO AVG 10Y
37.70%
DEBT TO ASSETS RATIO AVG 15Y
30.68%
DEBT TO ASSETS RATIO AVG 20Y
26.20%
CURRENT VS TTM AVG
+16.51%
CURRENT VS 3Y AVG
+37.05%
CURRENT VS 5Y AVG
+77.94%
CURRENT VS 10Y AVG
+84.02%
CURRENT VS 15Y AVG
+126.08%
CURRENT VS 20Y AVG
+164.77%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
+69273.02%
vs the sector median at left
Cytosorbents Corporation
Market Cap
$12.60M
Debt to Assets Ratio
69.37%
TTM Avg
59.54%
3Y Avg
50.62%
5Y Avg
38.99%
Market Cap
$12.56M
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.86M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.99M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$13.27M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.83M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.82M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.60M | 69.37% | 59.54% | 50.62% | 38.99% |
| Dare Bioscience, Inc. (DARE)vs › | $12.56M | 0.30% | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | 0.04% | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $12.92M | 0.00% | N/A | N/A | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $12.99M | 0.00% | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.12M | 0.15% | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.27M | 0.20% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.83M | 0.01% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.82M | 0.00% | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.62M | 0.31% | N/A | N/A | N/A |
Debt/Assets
69.4%
Debt/Equity
N/A
Current Ratio
0.66
Interest Coverage
-5.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 69.37% |
| 2026-03-31 | 46.75% |
| 2025-12-31 | 65.89% |
| 2025-09-30 | 59.31% |
| 2025-06-30 | 56.38% |
| 2025-03-31 | 53.12% |
| 2024-12-31 | 56.77% |
| 2024-09-30 | 56.08% |
| 2024-06-30 | 50.10% |
| 2024-03-31 | 37.41% |
| 2023-12-31 | 34.38% |
| 2023-09-30 | 37.92% |
| 2023-06-30 | 34.54% |
| 2023-03-31 | 31.64% |
| 2022-12-31 | 28.86% |
| 2022-09-30 | 21.50% |
| 2022-06-30 | 18.97% |
| 2022-03-31 | 16.40% |
| 2021-12-31 | 15.44% |
| 2021-09-30 | 14.36% |
| 2021-06-30 | 13.51% |
| 2021-03-31 | 1.06% |
| 2020-12-31 | 1.14% |
| 2020-09-30 | 15.62% |
| 2020-06-30 | 34.05% |
| 2020-03-31 | 36.31% |
| 2019-12-31 | 58.88% |
| 2019-09-30 | 56.43% |
| 2019-06-30 | 39.51% |
| 2019-03-31 | 36.54% |
| 2018-12-31 | 30.36% |
| 2018-09-30 | 28.96% |
| 2018-06-30 | 28.31% |
| 2018-03-31 | 34.87% |
| 2017-12-31 | 41.46% |
| 2017-09-30 | 44.86% |
| 2017-06-30 | 45.01% |
| 2017-03-31 | 59.44% |
| 2016-12-31 | 50.67% |
| 2016-09-30 | 45.10% |
| 2016-06-30 | 38.40% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 6.30% |
| 2014-03-31 | 13.94% |
| 2013-12-31 | 40.64% |
| 2013-09-30 | 38.66% |
| 2013-06-30 | 30.60% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 27.74% |
| 2012-09-30 | 29.78% |
| 2012-06-30 | 40.93% |
| 2012-03-31 | 41.21% |
| 2011-12-31 | 26.88% |
| 2011-09-30 | 15.77% |
| 2011-06-30 | 13.63% |
| 2011-03-31 | 17.18% |
| 2010-12-31 | 59.46% |
| 2010-09-30 | 78.51% |
| 2010-06-30 | 18.10% |
| 2010-03-31 | 10.22% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 2.79% |
| 2009-03-31 | 1.95% |
| 2008-12-31 | 1.48% |
| 2008-09-30 | 1.29% |
| 2008-06-30 | 1.21% |
| 2008-03-31 | 16.49% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 23.97% |
| 2006-06-30 | 17.93% |
| 2006-02-28 | 407.10% |
| 2005-11-30 | 347.32% |
| 2005-08-31 | 50.93% |
| 2005-05-31 | 200.00% |
| 2005-02-28 | 200.00% |
| 2004-11-30 | 21.70% |
